Codexis (CDXS)
(Delayed Data from NSDQ)
$2.62 USD
-0.12 (-4.38%)
Updated Sep 9, 2024 04:00 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CDXS 2.62 -0.12(-4.38%)
Will CDXS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CDXS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDXS
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
Codexis (CDXS) Tops Q4 Earnings and Revenue Estimates
CDXS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Low Occupancy Rate Affect Select Medical (SEM) Q4 Earnings?
ANSYS (ANSS) to Report Q4 Earnings: Here's What to Expect
WIX Set to Report Q4 Earnings: Here's What You Should Know
Other News for CDXS
Codexis Announces New Employment Inducement Grants
Codexis to Participate in Upcoming Healthcare Conferences
Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting
Apple, Lineage, OneStream initiated: Wall Street's top analyst calls
Codexis just downgraded at Benchmark, here's why